Authors
Latest:
Reflections on Decision-Making in Pediatric DermatologySmidt and Hunt offer insights on navigating pediatric dermatology decision-making, emphasizing learning from clinical scenarios and fostering a culture of feedback and improvement.
Latest:
Choosing Biologics for AD: Update Presented at ACAAIKaren S. Hsu Blatman, MD, shared key insights on biologics at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.
Latest:
Negotiating better managed care contractsJerri Ivey, director of revenue cycle management at VitalSkin Dermatology, shares steps you can take and ways you can educate yourself in order to negotiate better managed care contracts.
Latest:
Looking at the scalp and nails during a skin exam is keyA presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.
Latest:
Considering Laundry Care and Skin Care During National Eczema Awareness MonthLindsey Zubritsky, MD, FAAD, discusses the importance of providing accurate eczema care education throughout the month of October.
Latest:
Jenny Murase, MD: Providing Dermatologic Support in Postpartum CareMurase discussed safe dermatologic treatments during lactation, especially for chronic conditions needing biologics.
Latest:
Take-Home PointsJoshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.
Latest:
Addressing Differences in Patient Engagement Across Racial and Ethnic GroupsThere are interesting differences in the ways patients of varying ethnicities and races engage with technology.
Latest:
Tax Increases Coming? What Physicians Need to Know About the Inflation Reduction ActThe sweeping legislation contains tax code reform, health care provisions and climate change action. What does it mean for physicians?
Latest:
Adam Friedman, MD, FAAD: Exploring the Utilization of Immunomodulators as Therapeutic Interventions in Chronic Spontaneous UrticariaIn addition to recapping key highlights from his session, Friedman discusses what is new or upcoming in dermatology that most excites him.
Latest:
Tristan Hasbargen, PA-C: Closure Types in Mohs Surgery and MoreHasbargen presented Mohs surgery pearls on closure types and pattern recognition at the 2024 Diversity in Dermatology meeting.
Latest:
Grow Your Practice With the Right Marketing and SEONicole Vélez, MD, provided marketing pearls to streamline mundane tasks and promote your practice in the digital world.
Latest:
Addressing Patients' Concerns With BiosimilarsDrs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.
Latest:
2021 Acne Updates: New Drugs and ResearchA presentation from Maui Derm Live 2021 featured insights on new drugs and data in acne.
Latest:
Q&A: Diagnostic and Therapeutic Pearls for Pediatric DermatologyMancini discusses his SPD 2024 lecture, emphasizing off-label treatments, surrogate diagnostic markers, simpler therapies, and the importance of empathy and education.
Latest:
Rashmi Sarkar, MD, FAMS: Vitiligo and StigmaSarkar spoke with Dermatology Times after the ReV conference to discuss her session on vitiligo stigma.
Latest:
Cyltezo Biosimilar Launches Today in the USBoehringer Ingelheim’s Cyltezo is the first and only FDA-approved interchangeable biosimilar to adalimumab.
Latest:
The JAK Inhibitor Pipeline Builds in DermatologyEight JAK inhibitors are approved by the FDA to treat autoimmune, inflammatory, and allergic conditions.
Latest:
CBP/β-catenin Antagonists: A Safe and Novel Approach for Skin Rejuvenation and AgingTake a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.
Latest:
Further Research Needed to Study Link Between AD and ADHDResearchers found an association between ADHD and three inflammatory conditions—atopic dermatitis, otitis media, and herpes simplex infection.
Latest:
Roflumilast Patient Selection for Plaque Psoriasis TreatmentExperts describe roflumilast patient selection for plaque psoriasis treatment.
Latest:
Nivolumab Plus Talazoparib Does Not Induce Responses in Heavily Pretreated MelanomaNivolumab plus talazoparib did not produce RECIST-based tumor responses in heavily pretreated patients with unresectable or metastatic melanoma.
Latest:
Looking Ahead to the 2023 ACMS MeetingThe ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.
Latest:
Gut Microbiome Can Affect Radiation Cancer TreatmentThe overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.
Latest:
Clinical PresentationAndrew Alexis, MD, MPH, discusses how, in creating individualized treatment plans for vitiligo, clinicians must carefully consider the distinct challenges and response patterns associated with segmental vs nonsegmental forms, as segmental vitiligo tends to be more stable after initial progression but often more resistant to treatment, while nonsegmental vitiligo typically shows a more unpredictable course requiring ongoing management strategies.
